Rockefeller Capital Management L.P. Kura Oncology, Inc. Transaction History

Rockefeller Capital Management L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Mar 06, 2023	SELL	$11.23 - $16.9 $1,246 - $1,875	-111 Reduced 81.02%	26 $0
Q3 2022 Nov 02, 2022	SELL	$12.01 - $19.45 $4,035 - $6,535	-336 Reduced 71.04%	137 $1,000
Q2 2022 Aug 12, 2022	BUY	$10.71 - $18.33 $4,787 - $8,193	447 Added 1719.23%	473 $8,000
Q4 2021 Feb 14, 2022	BUY	$12.22 - $19.57 $317 - $508	26 New	26 $0
Q3 2021 Nov 12, 2021	SELL	$15.42 - $21.72 $447 - $629	-29 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$20.85 - $29.88 $604 - $866	29 New	29 $0

185

81.8M

42.1K

34K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $490M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.